Related Experiment Videos
Cancer genetics in primary care.
Duane Culler1, Sarah J Grimes, Louise S Acheson
1Center for Human Genetics, Case Western Reserve University, University Hospitals of Cleveland, 11100 Euclid Avenue, Lakeside 1500, Cleveland, OH 44106, USA.
Primary Care
|August 28, 2004
Summary
Genetic testing for breast cancer genes BRCA1 and BRCA2 is now common. Primary care clinicians must identify patients who need specialized hereditary cancer genetics services.
Area of Science:
- Oncology
- Genetics
- Medical Research
Background:
- The identification of BRCA1 and BRCA2 genes has increased public awareness of hereditary cancer genetics.
- Commercial genetic testing is now widely available.
- Advances in genetic testing and cancer risk assessment strategies are ongoing.
Purpose of the Study:
- To discuss the impact of genetic discoveries on public perception and clinical practice.
- To highlight the role of primary care in referring patients for hereditary cancer genetics services.
Main Methods:
- Literature review on BRCA1/BRCA2 gene cloning and genetic testing.
- Analysis of the implications for cancer risk assessment and patient management.
Main Results:
- Increased public interest in "cancer genes" and hereditary cancer.
- Growing responsibility for primary care clinicians in identifying at-risk individuals.
- Development of new strategies for cancer risk assessment and prevention.
Conclusions:
- The cloning of BRCA1 and BRCA2 has significantly advanced hereditary cancer genetics.
- Primary care plays a crucial role in navigating patients toward specialized genetic services.
- Ongoing research continues to improve cancer risk assessment and management strategies.